Hydroxyurea-Induced Interstitial Pneumonitis

A Rare Clinical Entity

Authors

  • Palwasha Kamal, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • Muhammad Imran, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology, & Rheumatology
  • Ayesha Irum, MBBS University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine
  • Heath Latham, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Pulmonary and Critical Care
  • Julian Magadan III, M.D. University of Kansas Medical Center, Kansas City, KS, Department of Internal Medicine; Division of Allergy, Clinical Immunology, & Rheumatology

DOI:

https://doi.org/10.17161/kjm.v10i2.8653

Keywords:

interstitial lung diseases, hydroxyurea, hypersensitivity

Metrics

Metrics Loading ...

Downloads

Published

2019-01-14

Issue

Vol. 10 No. 2 (2017)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Kamal, P., Imran, M., Irum, A., Latham, H., & Magadan III, J. (2019). Hydroxyurea-Induced Interstitial Pneumonitis: A Rare Clinical Entity. Kansas Journal of Medicine, 10(2), 47-49. https://doi.org/10.17161/kjm.v10i2.8653